SCHEMBL22601033

SCHEMBL22601033

O=C(N[S+]([O-])c1ccccc1-c1ccccc1)c1cc2ccccc2o1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.51
RAB9A P51151 9/20 0.51
TP53 P04637 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
PKM P14618 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
ALDH1A1 P00352 3/20 0.49
HPGD P15428 1/20 0.49
GALK1 P51570 1/20 0.47
LMNA P02545 2/20 0.46
THRB P10828 1/20 0.46
FLT3 P36888 1/20 0.46
BCAT1 P54687 1/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TSHR P16473 2/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22601061 0.89 CHRNA7 (0.40) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL22600839 0.88 RAB9A (0.41) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL24314307 0.88 RAB9A (0.45) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL24313789 0.88 NPC1 (0.43) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL22601146 0.86 NPC1 (0.39) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL26008098 0.86 SLC16A3 (0.42) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL24313952 0.85 NPC1 (0.43) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL24313970 0.85 ALDH1A1 (0.40) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL24314221 0.85 DRD3 (0.36) NPC1RAB9ATP53SMN1; SMN2PKM
SCHEMBL24313793 0.85 ALDH1A1 (0.42) NPC1RAB9ATP53SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3959202-B1 ACYL SULFONAMIDES FOR TREATING CANCER BAYER AG (DE) 2023-08-16 EP disclosed
WO-2020216701-A1 ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT (DE) 2020-10-29 WO disclosed